 Home > Biochemistry News > Biotechnology News > AstraZeneca's long-acting antibody cocktail therapy has positive results in the treatment of COVID-19 Phase III

AstraZeneca's long-acting antibody cocktail therapy has positive results in the treatment of COVID-19 Phase III

 Last Update: 2021-11-05
 Source: Internet
 Author: User

Tags

high c3 complement

calumet welding center

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Article source: Medical Rubik's Cube Info

Author: Shi Bei

On October 11, AstraZeneca announced that the long-acting antibody (LAAB) cocktail therapy AZD7442 has achieved positive and high-level results in the Phase III TACKLE trial for the treatment of COVID-19

AZD7442 is a combination of two long-acting antibodies, tixagevimab and cilgavimab

TACKLE is a phase III randomized, double-blind, placebo-controlled, multi-center trial designed to evaluate the safety and effectiveness of a single intramuscular injection of 600 mg AZD7442 compared with placebo in the outpatient treatment of COVID-19

The trial reached the primary endpoint.

In a pre-specified analysis of subjects who received treatment within 5 days of the onset of symptoms, AZD7442 reduced the risk of progression to severe COVID-19 or death (for any reason) by 67% compared with placebo.

AstraZeneca said it will discuss the data with health authorities

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.